- 2018 Annual Meeting Sponsors (21)
- 2019 Annual Meeting Sponsors (30)
- 2020 Annual Meeting Sponsors (17)
- ACL Blog: Stem Cells in Focus (31)
- Award Announcements (14)
- Events (29)
- Member News Items (162)
- Membership Application Requirements (4)
- Past Symposia (1)
- Past Symposia Programs (6)
- Policy News (102)
- Press Releases/Statements (140)
- Statements (84)
- Stem Cell Meetings (3)
- Stem Cell Reports Article (3)
- Year in Review (3)
-
-
-
-
-
-
-
-
-
-
-
-
ISSCR Urges UK Agency to Increase Enforcement for the Marketing of Unproven Products
The ISSCR writes UK agency to urge for increased enforcement activities to prevent the marketing and commercialization of stem cell-related products.Full story -
ISSCR Comments on Need to Improve ClinicalTrials.gov Database to Prevent Abuse
The ISSCR issues a comment letter urging that more efforts must be made to prevent the ClinicalTrials.gov database from being abused by clinics marketing unproven stem cell interventions.Full story -
ISSCR Statement on Ethical Standards for Stem Cell-based Embryo Models
The ISSCR is updating its Guidelines for Stem Cell Research and Clinical Translation to respond to recent scientific advances that include the use of pluripotent stem cell (PSC) to create models of early human embryo development.Full story -
The “I” in the ISSCR
The International Society for Stem Cell Research (ISSCR) is just that, an international organization. We work across the globe to promote excellence in stem cell science and applications to human health. The society advances international initiatives including: policy and advocacy, professional standards, building working relationships to stay abreast of emerging areas of interest, and of course educational meetings.Full story -
The ISSCR Hosts Ethics Workshop in China
The ISSCR and the Guangzhou Institute of Biomedicine and Health held a two-day workshop in Guangzhou, China. A small group of scientists and ethicists from around the world met to discuss ethical, scientific, and societal challenges in regenerative medicine.Full story -
The ISSCR is Updating its Guidelines
Stem cell science, its clinical application, and the ethical issues surrounding it have rapidly advanced since the release of the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation. The latest update will address important scientific, ethical, and regulatory issues, including embryo models, organoids, chimeras, genome editing, and the regulation and economics of cell therapies.Full story -
ISSCR Comments on Brazil’s Advanced Therapy Medicinal Products Regulation
The ISSCR submitted comments to Brazil’s health regulatory agency (ANVISA) regarding the proposed regulations for advanced therapy medicinal products that urge national governments to “maintain rigorous review pathways to ensure that stem cell-based products conform to the highest standards of evidence-based medicine.”Full story -
Lawrence Goldstein Policy Fellows Announced
The ISSCR is pleased to announce the recipients of the inaugural Lawrence Goldstein Policy Fellowship, Mohamed Abou El-Enein, PhD (Charité Universitätsmedizin, Berlin, Germany) and Zubin Master, PhD (Mayo Clinic, Rochester, MN, U.S.).Full story -
ISSCR Policy Advocacy in Action
Polices created by legislators and regulators can have a profound impact on stem cell and biomedical research and the development of new treatments. The ISSCR has been working on several fronts to advocate for responsible stem cell research and its application. Read more about the recent ISSCR-led fly in to Washington D.C. for discussions with government officials and our consultations with Google to prevent the marketing of unproven stem cell therapies.Full story